The STS/ACC TAVR In-Hospital Mortality Risk App assists clinicians in determining the predicted in-hospital mortality risk of a patient who is considering TAVR as a treatment option for AVR. Clinicians can evaluate a patient’s mortality risk and compare it to the national average based on STS/ACC TVT Registry data.